Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting

2005 ◽  
Vol 21 (12) ◽  
pp. 2063-2071 ◽  
Author(s):  
William J. Valentine ◽  
Andrew J. Palmer ◽  
Morten Lammert ◽  
Lars Nicklasson ◽  
Volker Foos ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Insulin Glargine ◽  
Biphasic Insulin ◽  
Effectiveness Analysis ◽  
Biphasic Insulin Aspart 30 ◽  
The Uk ◽  
Cost Outcomes

Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis

2018 ◽  
Vol 20 (8) ◽  
pp. 1921-1927 ◽  
Author(s):  
Anthony H. Barnett ◽  
Simon Arnoldini ◽  
Barnaby Hunt ◽  
Gowri Subramanian ◽  
Christina Stentoft Hoxer
Keyword(s):  
Type 2 Diabetes ◽  
Cost Effectiveness ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis ◽  
The Uk
Sign in / Sign up

Export Citation Format

Share Document